On “What’s Trending,” hosts Jessica Reyes, Patricia Wu, and guest MHTN Chief Medical Officer Dr. Dan Bober discuss a major change coming to drug advertising starting in May.
Side effects in plain sight
The FDA wants to end the practice of quickly rattling off risks in drug commercials, ensuring patients can truly understand them.
Focus on what matters
Dr. Bober recommends focusing on the most common and most serious side effects of a medication, rather than an overwhelming list.
Will the change be effective?Â
It’s unclear how strictly the new FDA rule will be enforced and whether it will significantly impact how drug ads are perceived.
